ResMed (RMD) Tops Q2 EPS by 8c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $226.74 +0.33%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.81, $0.08 better than the analyst estimate of $2.73. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
